blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3134413

EP3134413 - SUBSTITUTED [1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL COMPOUNDS AS PDE2 INHIBITORS [Right-click to bookmark this link]
Former [2017/09]SUBSTITUTED [1,2,4]TRIAZOLO [1,5-A]PYRIMIDIN-7-YL COMPOUNDS AS PDE2 INHIBITORS
[2018/28]
StatusNo opposition filed within time limit
Status updated on  17.07.2020
Database last updated on 19.07.2024
FormerThe patent has been granted
Status updated on  09.08.2019
FormerGrant of patent is intended
Status updated on  06.05.2019
FormerRequest for examination was made
Status updated on  10.04.2019
FormerGrant of patent is intended
Status updated on  28.11.2018
FormerRequest for examination was made
Status updated on  14.11.2018
FormerGrant of patent is intended
Status updated on  05.07.2018
FormerRequest for examination was made
Status updated on  27.01.2017
FormerThe international publication has been made
Status updated on  18.11.2016
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Dart NeuroScience (Cayman) Ltd.
10 Market Street No.774
Camana Bay
Grand Cayman KY1-9006 / KY
[2017/15]
Former [2017/09]For all designated states
Dart Neuroscience (Cayman) Ltd
10 Market Street No.774
Camana Bay
Grand Cayman, KY 1-9006 / KY
Inventor(s)01 / BREITENBUCHER, James
12278 Scripps Summit Drive
San Diego, CA 92131 / US
02 / FREESTONE, Graeme
12278 Scripps Summit Drive
San Diego, CA 92131 / US
03 / GOMEZ, Laurent
12278 Scripps Summit Drive
San Diego, CA 92131 / US
04 / LEMUS, Robert
12278 Scripps Summit Drive
San Diego, CA 92131 / US
05 / LY, Kiev
12278 Scripps Summit Drive
San Diego, CA 92131 / US
06 / MCCARRICK, Margaret
12278 Scripps Summit Drive
San Diego, CA 92131 / US
07 / VERNIER, William
12278 Scripps Summit Drive
San Diego, CA 92131 / US
08 / VICKERS, Troy
12278 Scripps Summit Drive
San Diego, CA 92131 / US
 [2017/09]
Representative(s)Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[2017/09]
Application number, filing date15721086.522.04.2015
[2017/09]
WO2015US27102
Priority number, dateUS201461983387P23.04.2014         Original published format: US 201461983387 P
[2017/09]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015164508
Date:29.10.2015
Language:EN
[2015/43]
Type: A1 Application with search report 
No.:EP3134413
Date:01.03.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 29.10.2015 takes the place of the publication of the European patent application.
[2017/09]
Type: B1 Patent specification 
No.:EP3134413
Date:11.09.2019
Language:EN
[2019/37]
Search report(s)International search report - published on:EP29.10.2015
ClassificationIPC:C07D487/04, C07D519/00, A61K31/505, A61P25/14
[2017/09]
CPC:
C07D487/04 (EP,CN,IL,KR,RU,US); A61K31/519 (EP,KR,RU,US); A61K31/4196 (KR);
A61P25/18 (US); A61P25/22 (US); A61P25/24 (US);
A61P25/28 (EP,US); C07D519/00 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/09]
Extension statesBA18.11.2016
ME18.11.2016
Validation statesMA18.11.2016
TitleGerman:SUBSTITUIERTE [1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL VERBINDUNGEN ALS PDE2-INHIBITOREN[2018/28]
English:SUBSTITUTED [1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL COMPOUNDS AS PDE2 INHIBITORS[2018/28]
French:COMPOSÉS DE [1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YLE SUBSTITUÉS UTILISABLES EN TANT QU'INHIBITEURS DE PDE2[2017/09]
Former [2017/09]SUBSTITUIERTE [ 1,2,4 ] TRIAZOLO [ 1,5-A ] PYRIMIDIN-7-YL VERBINDUNGEN ALS PDE2-INHIBITOREN
Former [2017/09]SUBSTITUTED [1,2,4]TRIAZOLO [1,5-A]PYRIMIDIN-7-YL COMPOUNDS AS PDE2 INHIBITORS
Entry into regional phase18.11.2016National basic fee paid 
18.11.2016Designation fee(s) paid 
18.11.2016Examination fee paid 
Examination procedure18.11.2016Examination requested  [2017/09]
18.11.2016Date on which the examining division has become responsible
13.04.2017Amendment by applicant (claims and/or description)
06.07.2018Communication of intention to grant the patent
08.11.2018Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
29.11.2018Communication of intention to grant the patent
09.04.2019Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
07.05.2019Communication of intention to grant the patent
30.07.2019Fee for grant paid
30.07.2019Fee for publishing/printing paid
30.07.2019Receipt of the translation of the claim(s)
Divisional application(s)EP19194930.4  / EP3597649
Opposition(s)15.06.2020No opposition filed within time limit [2020/34]
Fees paidRenewal fee
10.04.2017Renewal fee patent year 03
11.04.2018Renewal fee patent year 04
15.04.2019Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU22.04.2015
AL11.09.2019
CY11.09.2019
CZ11.09.2019
EE11.09.2019
FI11.09.2019
HR11.09.2019
LT11.09.2019
LV11.09.2019
MC11.09.2019
MK11.09.2019
MT11.09.2019
NL11.09.2019
PL11.09.2019
RO11.09.2019
RS11.09.2019
SE11.09.2019
SI11.09.2019
SK11.09.2019
SM11.09.2019
TR11.09.2019
BG11.12.2019
NO11.12.2019
GR12.12.2019
IS12.01.2020
PT13.01.2020
LU22.04.2020
[2022/32]
Former [2022/27]HU22.04.2015
AL11.09.2019
CY11.09.2019
CZ11.09.2019
EE11.09.2019
FI11.09.2019
HR11.09.2019
LT11.09.2019
LV11.09.2019
MC11.09.2019
MT11.09.2019
NL11.09.2019
PL11.09.2019
RO11.09.2019
RS11.09.2019
SE11.09.2019
SI11.09.2019
SK11.09.2019
SM11.09.2019
TR11.09.2019
BG11.12.2019
NO11.12.2019
GR12.12.2019
IS12.01.2020
PT13.01.2020
LU22.04.2020
Former [2021/08]AL11.09.2019
CZ11.09.2019
EE11.09.2019
FI11.09.2019
HR11.09.2019
LT11.09.2019
LV11.09.2019
MC11.09.2019
NL11.09.2019
PL11.09.2019
RO11.09.2019
RS11.09.2019
SE11.09.2019
SI11.09.2019
SK11.09.2019
SM11.09.2019
BG11.12.2019
NO11.12.2019
GR12.12.2019
IS12.01.2020
PT13.01.2020
LU22.04.2020
Former [2020/52]AL11.09.2019
CZ11.09.2019
EE11.09.2019
FI11.09.2019
HR11.09.2019
LT11.09.2019
LV11.09.2019
MC11.09.2019
NL11.09.2019
PL11.09.2019
RO11.09.2019
RS11.09.2019
SE11.09.2019
SI11.09.2019
SK11.09.2019
SM11.09.2019
BG11.12.2019
NO11.12.2019
GR12.12.2019
IS12.01.2020
PT13.01.2020
Former [2020/37]AL11.09.2019
CZ11.09.2019
EE11.09.2019
FI11.09.2019
HR11.09.2019
LT11.09.2019
LV11.09.2019
NL11.09.2019
PL11.09.2019
RO11.09.2019
RS11.09.2019
SE11.09.2019
SI11.09.2019
SK11.09.2019
SM11.09.2019
BG11.12.2019
NO11.12.2019
GR12.12.2019
IS12.01.2020
PT13.01.2020
Former [2020/36]AL11.09.2019
CZ11.09.2019
EE11.09.2019
FI11.09.2019
HR11.09.2019
LT11.09.2019
LV11.09.2019
NL11.09.2019
PL11.09.2019
RO11.09.2019
RS11.09.2019
SE11.09.2019
SK11.09.2019
SM11.09.2019
BG11.12.2019
NO11.12.2019
GR12.12.2019
IS12.01.2020
PT13.01.2020
Former [2020/27]AL11.09.2019
CZ11.09.2019
EE11.09.2019
FI11.09.2019
HR11.09.2019
LT11.09.2019
LV11.09.2019
NL11.09.2019
PL11.09.2019
RO11.09.2019
RS11.09.2019
SE11.09.2019
SK11.09.2019
SM11.09.2019
BG11.12.2019
NO11.12.2019
GR12.12.2019
PT13.01.2020
IS24.02.2020
Former [2020/25]AL11.09.2019
CZ11.09.2019
EE11.09.2019
FI11.09.2019
HR11.09.2019
LT11.09.2019
LV11.09.2019
NL11.09.2019
PL11.09.2019
RO11.09.2019
RS11.09.2019
SE11.09.2019
SK11.09.2019
BG11.12.2019
NO11.12.2019
GR12.12.2019
PT13.01.2020
IS24.02.2020
Former [2020/23]AL11.09.2019
EE11.09.2019
FI11.09.2019
HR11.09.2019
LT11.09.2019
LV11.09.2019
NL11.09.2019
PL11.09.2019
RO11.09.2019
RS11.09.2019
SE11.09.2019
BG11.12.2019
NO11.12.2019
GR12.12.2019
PT13.01.2020
Former [2020/22]AL11.09.2019
EE11.09.2019
FI11.09.2019
HR11.09.2019
LT11.09.2019
LV11.09.2019
NL11.09.2019
RS11.09.2019
SE11.09.2019
BG11.12.2019
NO11.12.2019
GR12.12.2019
PT13.01.2020
Former [2020/20]AL11.09.2019
FI11.09.2019
HR11.09.2019
LT11.09.2019
LV11.09.2019
NL11.09.2019
RS11.09.2019
SE11.09.2019
BG11.12.2019
NO11.12.2019
GR12.12.2019
Former [2020/15]AL11.09.2019
FI11.09.2019
HR11.09.2019
LT11.09.2019
LV11.09.2019
RS11.09.2019
SE11.09.2019
BG11.12.2019
NO11.12.2019
GR12.12.2019
Former [2020/11]FI11.09.2019
HR11.09.2019
LT11.09.2019
LV11.09.2019
RS11.09.2019
SE11.09.2019
BG11.12.2019
NO11.12.2019
GR12.12.2019
Former [2020/10]FI11.09.2019
LT11.09.2019
SE11.09.2019
BG11.12.2019
NO11.12.2019
Former [2020/09]FI11.09.2019
LT11.09.2019
NO11.12.2019
Former [2020/08]LT11.09.2019
NO11.12.2019
Cited inInternational search[A]US4447438  (LEDELEC LUCIEN [FR], et al);
 [A]US2012214791  (HELAL CHRISTOPHER JOHN [US], et al);
 [AD]US8598155  (HELAL CHRISTOPHER JOHN [US], et al)
by applicantUS4938949
 US6573263
 EP1363912
 WO2004044234
 WO2004108136
 WO2005041957
 US2008188525
 US7410963
 US2009053140
 US7671050
 WO2010054260
 WO2010054253
 US7851472
 US7868015
 WO2011011312
 US7947731
 US8106047
 WO2012104293
 WO2012168817
 WO2013000924
 WO2013034755
 WO2013034758
 WO2013034761
 US8598155
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.